Studies on preparation of erythromycin enteric pellets by aqueous coating process

陈挺,张焱,陈庆华,孙忠民,孙培红,崔一民
DOI: https://doi.org/10.3321/j.issn:1001-2494.2002.06.011
2002-01-01
Abstract:OBJECTIVE: The aqueous acrylic coating process was adopted to develop the erythromycin enteric pellets. METHOD: The erythromycin pellets were developed by layering technique, and were coated by aqueous coating formulation (Eudragit L100-55) in tangential spray fluid-bed. The drug release profiles in vitro and stability of coated pellets were studied. The bioavailability of enteric capsules were studied in 20 healthy male volunteers, the imported capsules were used as the reference. RESULTS: The acrylic coated pellets showed enteric release profiles in vitro. Less than 10 % of the drug was released in pH1. 2 HCl solution, while the drug was quickly released in pH6.8 buffer. The coated pellets were stable after storage for 3 months. The pharmacokinetic results showed that the erythromycin enteric capsule was bioequivalent to the imported capsule, and the relative bioavailability was (100.59 ± 19.47)%. CONCLUSION: The erythromycin enteric pellets can be developed by the aqueous acrylic coating process with good reproduction and stability.
What problem does this paper attempt to address?